n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine has been researched along with potassium chloride in 1 studies
| Studies (n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine) | Trials (n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine) | Recent Studies (post-2010) (n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine) | Studies (potassium chloride) | Trials (potassium chloride) | Recent Studies (post-2010) (potassium chloride) |
|---|---|---|---|---|---|
| 79 | 1 | 16 | 18,040 | 395 | 1,764 |
| Protein | Taxonomy | n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine (IC50) | potassium chloride (IC50) |
|---|---|---|---|
| Sodium/potassium/calcium exchanger 4 | Homo sapiens (human) | 174000 | |
| Sodium/potassium/calcium exchanger 2 | Homo sapiens (human) | 280000 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hook, VY; Reisine, TD | 1 |
1 other study(ies) available for n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine and potassium chloride
| Article | Year |
|---|---|
Cysteine proteases are the major beta-secretase in the regulated secretory pathway that provides most of the beta-amyloid in Alzheimer's disease: role of BACE 1 in the constitutive secretory pathway.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Aspartic Acid Endopeptidases; Cells, Cultured; Chromaffin Cells; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Dithiothreitol; Endopeptidases; Extracellular Space; Glutathione; Leucine; Mice; Mice, Knockout; Mutation; Neurons; Nicotine; Nicotinic Agonists; Peptide Fragments; Potassium Chloride; Secretory Vesicles; Substrate Specificity; Time Factors | 2003 |